| Primary |
| Glaucoma |
20.0% |
| Hypertension |
20.0% |
| Oedema |
20.0% |
| Arthralgia |
10.0% |
| Depression |
10.0% |
| Mineral Supplementation |
10.0% |
| Vitamin D Decreased |
10.0% |
|
| Blood Creatinine Increased |
11.1% |
| Drug Interaction |
11.1% |
| Hyperkalaemia |
11.1% |
| Muscle Spasms |
11.1% |
| Oedema |
11.1% |
| Pancreatitis Acute |
11.1% |
| Pollakiuria |
11.1% |
| Renal Impairment |
11.1% |
| Urticaria |
11.1% |
|
| Secondary |
| Product Used For Unknown Indication |
36.2% |
| Hypertension |
27.6% |
| Drug Use For Unknown Indication |
8.6% |
| Pulmonary Arterial Hypertension |
2.9% |
| Rheumatoid Arthritis |
2.9% |
| Psoriasis |
2.4% |
| Diabetes Mellitus |
1.9% |
| Hormone Replacement Therapy |
1.9% |
| Open Wound |
1.9% |
| Arthritis |
1.4% |
| Breast Cancer |
1.4% |
| Depression |
1.4% |
| Fibromyalgia |
1.4% |
| Oedema Peripheral |
1.4% |
| Pain |
1.4% |
| Pain In Extremity |
1.4% |
| Blood Glucose Increased |
1.0% |
| Cardiac Pacemaker Insertion |
1.0% |
| Deafness |
1.0% |
| Fluid Retention |
1.0% |
|
| Completed Suicide |
15.9% |
| Stress Cardiomyopathy |
13.6% |
| Toxicity To Various Agents |
6.8% |
| Labelled Drug-drug Interaction Medication Error |
4.5% |
| Lipase Increased |
4.5% |
| Oedema Peripheral |
4.5% |
| Pain |
4.5% |
| Poisoning |
4.5% |
| Swelling Face |
4.5% |
| Transient Acantholytic Dermatosis |
4.5% |
| Tremor |
4.5% |
| Urticaria |
4.5% |
| Weight Decreased |
4.5% |
| Weight Increased |
4.5% |
| Abasia |
2.3% |
| Abdominal Pain Upper |
2.3% |
| Anaemia |
2.3% |
| Blood Test Abnormal |
2.3% |
| Cerebrovascular Accident |
2.3% |
| Cerebrovascular Disorder |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
23.8% |
| Drug Use For Unknown Indication |
17.9% |
| Hypertension |
14.7% |
| Rheumatoid Arthritis |
4.6% |
| Blood Cholesterol Increased |
4.0% |
| Pain |
3.7% |
| Depression |
3.7% |
| Gastrooesophageal Reflux Disease |
3.2% |
| Osteoporosis |
2.7% |
| Hormone Replacement Therapy |
2.4% |
| Asthma |
2.3% |
| Chronic Obstructive Pulmonary Disease |
2.3% |
| Anxiety |
2.2% |
| Diabetes Mellitus |
2.2% |
| Blood Pressure |
2.1% |
| Arthritis |
1.8% |
| Smoking Cessation Therapy |
1.7% |
| Atrial Fibrillation |
1.7% |
| Prophylaxis |
1.5% |
| Hypothyroidism |
1.5% |
|
| Vomiting |
13.7% |
| Weight Decreased |
10.2% |
| Pain |
8.1% |
| Weight Increased |
7.6% |
| Flushing |
5.1% |
| Nausea |
5.1% |
| Drug Ineffective |
4.8% |
| Vision Blurred |
4.4% |
| Dyspnoea |
4.1% |
| Tremor |
4.1% |
| Urinary Tract Infection |
3.8% |
| Pain In Extremity |
3.6% |
| Pruritus |
3.6% |
| Myocardial Infarction |
3.5% |
| Rash |
3.3% |
| Transient Ischaemic Attack |
3.3% |
| Breast Cancer Female |
3.1% |
| Renal Failure Acute |
3.0% |
| Somnolence |
3.0% |
| Insomnia |
2.6% |
|
| Interacting |
| Arthritis |
16.7% |
| Hypertension |
16.7% |
| Blood Glucose Increased |
8.3% |
| Cardiac Pacemaker Insertion |
8.3% |
| Diabetes Mellitus |
8.3% |
| Diuretic Therapy |
8.3% |
| Gastrooesophageal Reflux Disease |
8.3% |
| Heart Rate Irregular |
8.3% |
| Hypoaesthesia |
8.3% |
| Pain |
8.3% |
|
| Urticaria |
28.6% |
| Diarrhoea |
14.3% |
| Labelled Drug-drug Interaction Medication Error |
14.3% |
| Pain In Extremity |
14.3% |
| Skin Exfoliation |
14.3% |
| Transient Acantholytic Dermatosis |
14.3% |
|
